Jyothy Labs News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Jyothy Labs Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Jyothy Labs Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Jyothy Labs from all sources in a single place.

Jyothy Labs Ltd.

17 Nov 2025

SAST

Jyothy Labs Ltd - 532926 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M P Ramachandran Family Trust I & PACs

pdf

Jyothy Labs Ltd.

15 Nov 2025

Earnings Call

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the earnings Call held on Wednesday, November 12, 2025 for analyst / investors to discuss the Un-audited financial results for the quarter and half year ended September 30, 2025 and the way forward

pdf

Jyothy Labs Ltd.

15 Nov 2025

Company Update

Jyothy Labs Ltd - 532926 - Disclosure Under Regulation 30 Read With Schedule III Of The …

BSE India

Disclosure under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Jyothy Labs Ltd.

15 Nov 2025

Company Update

Jyothy Labs Ltd - 532926 - General-Updates

BSE India

Addition in members of the promoter Group of the Company

pdf

Jyothy Labs Ltd.

14 Nov 2025

Company Update

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Announcement under Regulation 30 (LODR) - Analyst / Investor Meet

pdf

Jyothy Labs Ltd.

13 Nov 2025, 02:50PM

Company Update

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication

pdf

Jyothy Labs Ltd.

13 Nov 2025, 12:54PM

Jyothy Labs Q2 Review Weak Quarter Despite Volume Growth, Says Motilal Oswal Maintaining 'Neutral' Stance

NDTV Profit

Market share gains, the success of new launches, a recovery in personal care, and the turnaround of HI portfolio will be crucial for Jyothy Labs' earnings growth.

Jyothy Labs Ltd. has an average target of 375.40 from 5 brokers.

Jyothy Labs Ltd.

13 Nov 2025, 12:00AM

Short-term disruption; recovery on track

Buy: Jyothy Labs Ltd.

Target

ICICI Securities Limited

JYL’s Q2FY26 performance was impacted by GST-led disruption and pricing/grammage adjustments (value/volume growth of 0.4%/2.8% YoY).

Jyothy Labs Ltd. has an average target of 375.40 from 5 brokers.

Jyothy Labs Ltd.

13 Nov 2025, 12:00AM

Result Update:Jyothy Labs

Hold: Jyothy Labs Ltd.

Target

Axis Direct

Considering the near-term challenges, we maintain our HOLD rating on the stock and revise our TP to Rs 320/share. The TP implies an upside potential of 3% from the CMP.